Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03653442
Other study ID # Reg. 2018/0051
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 10, 2018
Est. completion date January 1, 2020

Study information

Verified date March 2020
Source Papa Giovanni XXIII Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Spinal (or neuraxial) anaesthesia is still considered the first choice technique for elective Caesarean section as simple, quick, reliable and cheap. However, this anaesthetic method can be burdened by maternal hypotension with significant maternal and foetal implications.


Description:

Hypotension induced by neuraxial anaesthesia (NA-induced hypotension) is defined as systolic blood pressure (SBP) less than 100 mmHg or a decrease of 20-30% from baseline values. The incidence of hypotension could exceed 71% and can cause, if serious and prolonged, nausea, vomiting, lost of consciousness, placental hypoperfusion and foetal acidosis.

There are two alternative hypotheses to explain why hypotension might be so commonly diagnosed after regional analgesia during labour: preload reduction theory and afterload reduction theory. A non-invasive continue haemodynamic monitoring could be useful in detecting pregnant women with a positive preoperative supine stress, at increased risk for clinically significant hypotension during Caesarean section under spinal anaesthesia. These women seem more likely to benefit from optimizing the administration of fluids and vasoconstrictors to maintain pressure and cardiac output at basal levels.

Predictors of clinical need of therapy to counteract symptomatic hypotension (dependant variable) will be sought by using regression logistic analysis. Putative variable to include in the model will be selected through clinical and statistical criteria. Univariate screening will be performed assuming the usual cut-off of p<0,1 and taking into account the biological relevance. The final variable to challenge in the multivariate model will be selected according to the parsimony criteria in order to avoid overfitting and multicollinearity.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date January 1, 2020
Est. primary completion date December 1, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Pregnant women with high bleeding risk (previous caesarean section, previous uterine surgery, placenta praevia/accrete, previous documented uterine atony, foetal macrosomia, polyhydramnios)

- Obstetric nulliparous or multiparous patients

- Spontaneous pregnancy

- Single foetus, at term

- Elective Caesarean section, fasting according to international guidelines

- At term BMI > 18 and < 35 kg/m2

Exclusion Criteria:

- Contraindications to neuraxial anaesthesia

- Previous documented maternal cardiovascular problems

- Gestational hypertension (defined as new onset systolic blood pressure = 140 mmHg or diastolic blood pressure = 90 mmHg on two occasions at east 4 - 6 hours apart while the patient is on bed rest, with an appropriately sized cuff, after 20 weeks gestation)

- Chronic hypertension of any causes (defined as systemic blood pressure > 140/90 mmHg)

- Preeclampsia (defined as gestational hypertension with one or more of the following de novo conditions:

- Proteinuria (defined as the excretion of 300 mg or more of protein in a 24-hour urine collection or a protein/creatinine ratio of at least 0.3 (each measured as mg/dL) or at least 1 g/L [2+] on dipstick testing)

- Other maternal organ dysfunction:

1. progressive renal insufficiency (renal creatinine concentration greater than 1.1 mg/dL or a doubling of the serum creatinine concentration in the absence of other renal disease),

2. impaired liver function as indicated by abnormally elevated blood concentrations of liver enzymes (at least twice upper limit of normal concentration), severe persistent right upper quadrant or epigastric pain unresponsive to medication and not accounted for by alternative diagnoses, or both),

3. new-onset cerebral or visual disturbances (examples include eclampsia, altered mental status, blindness, stroke, or more commonly hyperreflexia when accompanied by clonus, severe headaches when accompanied by hyperreflexia, persistent visual scotoma),

4. haematological complications (thrombocytopenia - platelet count below 150,000/dL, disseminated intravascular coagulation (DIC), haemolysis).

- Uteroplacental dysfunction with foetal growth restriction (less than fifth percentile)

- Reversed end-diastolic flow on umbilical artery Doppler studies (IR > 0,5 at 24 week gestation)

Study Design


Locations

Country Name City State
Italy Asst Papa Giovanni Xxiii Bergamo

Sponsors (1)

Lead Sponsor Collaborator
Papa Giovanni XXIII Hospital

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stress tests and Systolic blood pressure to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Systolic blood pressure in mmHg) and neuraxial anaesthesia induced hypotension (clinical end point) before Caesarean section
Primary Stress tests and Diastolic blood pressure to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Diastolic blood pressure in mmHg) and neuraxial anaesthesia induced hypotension (clinical end point) before Caesarean section
Primary Stress tests and Mean arterial blood pressure to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Mean arterial blood pressure in mmHg) and neuraxial anaesthesia induced hypotension (clinical end point) before Caesarean section
Primary Stress tests and Heart rate to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Heart rate in beats per minute) and neuraxial anaesthesia induced hypotension (clinical end point) before Caesarean section
Primary Stress tests and Cardiac output to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Cardiac output in L/min) and neuraxial anaesthesia induced hypotension (clinical end point) before Caesarean section
Primary Stress tests and Stroke volume to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Stroke volume in mL/beat) and neuraxial anaesthesia induced hypotension (clinical end point) before Caesarean section
Primary Stress tests and Systemic vascular resistance to identify correlations among stress tests (supine, deep breath in supine, left lateral, deep breath in left lateral, standing, deep breath in standing, leg raising), non-invasive haemodynamic parameter detected (Systemic vascular resistance in dynes - sec/cm^5) and neuraxial anaesthesia induced hypotension (clinical end point) before Caesarean section
Secondary Neuraxial induced hypotension Neuraxial induced hypotension is defined as a reduction of SBP < 100 mmHg or a decrease by 20 - 30%, compared to basal value from immediately after induction of spinal anaesthesia to 15 minutes later
See also
  Status Clinical Trial Phase
Terminated NCT03638011 - A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine Phase 4
Completed NCT04238741 - Audio-recording of Consent for Anaesthesia for Elective Caesarean Section N/A
Completed NCT01718236 - Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section Phase 4
Completed NCT03199170 - Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section N/A
Completed NCT03309163 - Effect of Tramadol in Prevention of Postpartum Depression Phase 4
Completed NCT03711552 - Validation of an Obstetric QoR Score and to Establish Its MCID.
Not yet recruiting NCT05583214 - Evaluating the Effectiveness of Ondansetron Versus Dexamethasone Versus Placebo for the Control of Intraoperative Nausea and Vomiting in Patients Undergoing Lower-segment Caesarean Section Under Spinal Anesthesia Phase 4
Recruiting NCT06070844 - Yoga Nidra and Pain After Caesarean Section N/A
Recruiting NCT06070792 - Neurolinguistic Programming, Progressive Muscle Relaxation Exercises, and Breastfeeding N/A
Recruiting NCT06135961 - Intrapartum Non-invasive Electrophysiological Monitoring N/A
Terminated NCT04435496 - Study to Evaluate the Learning Curve to Anchor GYN-CS® Device N/A
Completed NCT00916812 - Sensitivity of Hyomental Distance Ratio as a Single Predictor of Difficult Intubation in Obstetrics
Completed NCT05520580 - Effect of Mother's Push at Cesarean Delivery Mother's PUSHING AT CS A RANDOMIZED CONTROLLED TRIAL N/A
Recruiting NCT02755168 - External Pop-Out Technique Versus Classic Head Extraction During Cesarean Section N/A
Completed NCT02285569 - The Pleth Variability Index and Hypotension at Caesarean Under Spinal. N/A
Completed NCT01210300 - Exploring Taiwanese Womens' Decision-making Regarding Vaginal Birth After Caesarean Section N/A
Completed NCT03134677 - The Effects of Different Anesthetic Techniques on QT, Corrected QT (QTc), and P Wave Dispersions in Cesarean Section Phase 4
Not yet recruiting NCT05446311 - Naldebain® Extended-release Injection After Cesarean Section in Pain Management
Completed NCT01278238 - Optimization of Hemodynamic Conditions During Caesarean Section Under Spinal Anaesthesia N/A
Completed NCT04172727 - Subarachnoid Block With Ultrasound-Guided Transversalis Fascia Plane Block for Cesarean Section Phase 4